Regulator Says Pfizer Used Misleading Advertisement
The U.S. Food and Drug Administration posted a letter it had written to Pfizer on its Web site Monday, in which it claimed Pfizer's advertisement misbranded the drug in violation of the Federal Food, Drug and Cosmetic Act.
Geodon is used to treat acute agitation in schizophrenic patients. The FDA said the drug is associated...
To view the full article, register now.